Animal models of cancer pain
Abstract
Modern cancer therapies have significantly increased patient survival rates in both human and veterinary medicine. Since cancer patients live longer they now face new challenges resulting from severe, chronic tumor-induced pain. Unrelieved cancer pain significantly decreases the quality of life of such patients; thus the goal of pain management is to not only to alleviate pain, but also to maintain the patient's physiological and psychological well-being. The major impediment for developing new treatments for cancer pain has been our limited knowledge of the basic mechanisms that drive cancer pain and the lack of adequate animal cancer pain models to study the molecular, biochemical and neurobiological pathways that generate and maintain cancer pain. However this situation has recently changed with the recent development of several novel animal models of cancer pain. This review will focus on describing these animal models, many of them in rodents, and reviewing some of the recent information gained from the use of these models to investigate the basic mechanims that underlie the development and maintenance of cancer pain. Animal models of cancer pain can be divided into the following five categories: bone cancer pain models, non-bone cancer pain models, cancer invasion pain models, cancer chemotherapeutic-induced peripheral neuropathy models, and spontaneous occurring cancer pain models. These models will be important not only for enhancing our knowledge of how cancer pain is generated, but more importantly for the development of novel therapeutic regimes to treat cancer pain in both domestic animals and humans.
Similar articles
-
Evolving cancer pain treatments: rational approaches to improve the quality of life for cancer patients.Curr Pharm Biotechnol. 2011 Oct;12(10):1627-43. doi: 10.2174/138920111798357267. Curr Pharm Biotechnol. 2011. PMID: 21466450 Review.
-
Animal models for studying the etiology and treatment of low back pain.J Orthop Res. 2018 May;36(5):1305-1312. doi: 10.1002/jor.23741. Epub 2018 Mar 14. J Orthop Res. 2018. PMID: 28921656 Free PMC article. Review.
-
Translational pain assessment: could natural animal models be the missing link?Pain. 2017 Sep;158(9):1633-1646. doi: 10.1097/j.pain.0000000000000978. Pain. 2017. PMID: 28614187 Review.
-
[Bone cancer pain: from preclinical pharmacology to clinical trials].Gac Med Mex. 2013 Mar-Apr;149(2):204-11. Gac Med Mex. 2013. PMID: 23652187 Review. Spanish.
-
[Mechanisms underlying generation of cancer pain].Masui. 2011 Sep;60(9):1010-7. Masui. 2011. PMID: 21950031 Japanese.
Cited by
-
Pain: Persistent postsurgery and bone cancer-related pain.J Int Med Res. 2019 Feb;47(2):528-543. doi: 10.1177/0300060518818296. Epub 2019 Jan 11. J Int Med Res. 2019. PMID: 30632434 Free PMC article. Review.
-
Predictive validity of behavioural animal models for chronic pain.Br J Pharmacol. 2011 Oct;164(4):1195-206. doi: 10.1111/j.1476-5381.2011.01300.x. Br J Pharmacol. 2011. PMID: 21371010 Free PMC article. Review.
-
Metastatic human breast cancer to the spine produces mechanical hyperalgesia and gait deficits in rodents.Spine J. 2017 Sep;17(9):1325-1334. doi: 10.1016/j.spinee.2017.04.009. Epub 2017 Apr 13. Spine J. 2017. PMID: 28412561 Free PMC article.
-
Optimization and In Vivo Profiling of a Refined Rat Model of Walker 256 Breast Cancer Cell-Induced Bone Pain Using Behavioral, Radiological, Histological, Immunohistochemical and Pharmacological Methods.Front Pharmacol. 2017 Jul 6;8:442. doi: 10.3389/fphar.2017.00442. eCollection 2017. Front Pharmacol. 2017. PMID: 28729837 Free PMC article.
-
Preventive or late administration of anti-NGF therapy attenuates tumor-induced nerve sprouting, neuroma formation, and cancer pain.Pain. 2011 Nov;152(11):2564-2574. doi: 10.1016/j.pain.2011.07.020. Epub 2011 Sep 9. Pain. 2011. PMID: 21907491 Free PMC article.
References
-
- Aley KO, Reichling DB, Levine JD. 1996. Vincristine hyperalgesia in the rat: a model of painful vincristine neuropathy in humans. Neuroscience 73:259–265 - PubMed
-
- Allen JW, Mantyh PW, Horais K, Tozier N, Rogers SD, Ghilardi JR, Cizkova D, Grafe MR, Richter P, Lappi DA, Yaksh TL. 2006. Safety evaluation of intrathecal substance P–saporin, a targeted neurotoxin, in dogs. Toxicol Sci 91:286–298 - PubMed
-
- Andersen C, Bagi CM, Adams SW. 2003. Intratibial injection of human prostate cancer cell line CWR22 elicits osteoblastic response in immunodeficient rats. J Musculoskelet Neuronal Interact 3:148–155 - PubMed
-
- Apfel SC, Lipton RB, Arezzo JC, Kessler JA. 1991. Nerve growth factor prevents toxic neuropathy in mice. Ann Neurol 29:87–90 - PubMed
-
- Asai H, Ozaki N, Shinoda M, Nagamine K, Tohnai I, Ueda M, Sugiura Y. 2005. Heat and mechanical hyperalgesia in mice model of cancer pain. Pain 117:19–29 - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical